Vila J - Search Results

1

Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals.

Biron F, Lucht F, Peyramond D, Fresard A, Vallet T, Nugier F, Grange J, Malley S, Hamedi-Sangsari F, Vila J. Biron F, et al. Among authors: vila j. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):36-40. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7648282 Clinical Trial.

2

Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals.

Biron F, Lucht F, Peyramond D, Fresard A, Vallet T, Nugier F, Grange J, Malley S, Hamedi-Sangsari F, Vila J. Biron F, et al. Among authors: vila j. Antiviral Res. 1996 Jan;29(1):111-3. doi: 10.1016/0166-3542(95)00931-0. Antiviral Res. 1996. PMID: 8721560 Clinical Trial. No abstract available.

3

Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.

Malley SD, Grange JM, Hamedi-Sangsari F, Vila JR. Malley SD, et al. Among authors: vila jr. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11017-21. doi: 10.1073/pnas.91.23.11017. Proc Natl Acad Sci U S A. 1994. PMID: 7972000 Free PMC article.

4

1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection.

Vila J, Biron F, Nugier F, Vallet T, Peyramond D. Vila J, et al. Lancet. 1996 Jul 20;348(9021):203-4. doi: 10.1016/s0140-6736(05)66157-0. Lancet. 1996. PMID: 8684186 No abstract available.

5

Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide.

Vila J, Nugier F, Barguès G, Vallet T, Peyramond D, Hamedi-Sangsari F, Seigneurin JM. Vila J, et al. Lancet. 1997 Aug 30;350(9078):635-6. doi: 10.1016/S0140-6736(97)24035-3. Lancet. 1997. PMID: 9288048 No abstract available.

6

Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compounds.

Malley SD, Grange JM, Hamedi-Sangsari F, Vila JR. Malley SD, et al. Among authors: vila jr. Lancet. 1994 May 21;343(8908):1292. doi: 10.1016/s0140-6736(94)92182-2. Lancet. 1994. PMID: 7910296 No abstract available.

7

Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.

Tournaire R, Arnaud S, Hamedi-Sangsari F, Malley S, Grange J, Blanchet JP, Doré JF, Vila J. Tournaire R, et al. Among authors: vila j. Leukemia. 1994 Oct;8(10):1703-7. Leukemia. 1994. PMID: 7934166

8

Therapeutic effects of D-aspartic acid beta-hydroxamate (DAH) on Friend erythroleukemia.

Tournaire R, Malley S, Hamedi-Sangsari F, Thomasset N, Grange J, Dore JF, Vila J. Tournaire R, et al. Among authors: vila j. Int J Cancer. 1994 Aug 1;58(3):420-5. doi: 10.1002/ijc.2910580319. Int J Cancer. 1994. PMID: 8050823

9

Anti-tumoral activity of L and D isomers of aspartic acid beta-hydroxamate on L5178Y leukemia.

Thomasset N, Hamedi-Sangsari F, Tournaire R, Navarro C, Malley S, Goetsch L, Grange J, Vila J. Thomasset N, et al. Among authors: vila j. Int J Cancer. 1991 Sep 30;49(3):421-4. doi: 10.1002/ijc.2910490319. Int J Cancer. 1991. PMID: 1917141

10

Neurotoxic effect of the anti-HIV drug D-aspartate beta-hydroxamate for rat primary neuronal cultures: attenuation by N-methyl-D-aspartate (NMDA) antagonists.

Lockhart BP, Vila J, Hamedi-Sangsari F, Privat A, Vignon J. Lockhart BP, et al. Among authors: vila j. Brain Res. 1993 Dec 10;630(1-2):32-40. doi: 10.1016/0006-8993(93)90639-5. Brain Res. 1993. PMID: 8118699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,602 results

Search Page

Filters